Flagship Pioneering Fund Vii General Partner Llc - Net Worth and Insider Trading
Flagship Pioneering Fund Vii General Partner Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Flagship Pioneering Fund Vii General Partner Llc owns 3 companies in total, including Evelo Biosciences Inc (EVLO) , Seres Therapeutics Inc (MCRB) , and Omega Therapeutics Inc (OMGA) .
Insider Ownership Summary of Flagship Pioneering Fund Vii General Partner Llc
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
EVLO | Evelo Biosciences Inc | 2022-05-27 | 10 percent owner |
MCRB | Seres Therapeutics Inc | 2022-07-05 | 10 percent owner |
OMGA | Omega Therapeutics Inc | 2023-02-27 | 10 percent owner |
Flagship Pioneering Fund Vii General Partner Llc Trading Performance
Flagship Pioneering Fund Vii General Partner Llc Ownership Network
Ownership Network List of Flagship Pioneering Fund Vii General Partner Llc
Ownership Network Relation of Flagship Pioneering Fund Vii General Partner Llc
Flagship Pioneering Fund Vii General Partner Llc Owned Company Details
What does Evelo Biosciences Inc do?
Who are the key executives at Evelo Biosciences Inc?
Flagship Pioneering Fund Vii General Partner Llc is the 10 percent owner of Evelo Biosciences Inc. Other key executives at Evelo Biosciences Inc include Chief Medical Officer Duncan Mchale , Chief Financial Officer Marella Thorell , and See Remarks Mark Bodmer .
Evelo Biosciences Inc (EVLO) Insider Trades Summary
Over the past 18 months, Flagship Pioneering Fund Vii General Partner Llc made no insider transaction in Evelo Biosciences Inc (EVLO). Other recent insider transactions involving Evelo Biosciences Inc (EVLO) include a net sale of 103,730 shares made by Mark Bodmer , a net sale of 80,121 shares made by Duncan Mchale , and a net sale of 46,345 shares made by Marella Thorell .
In summary, during the past 3 months, insiders sold 0 shares of Evelo Biosciences Inc (EVLO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 46,829 shares of Evelo Biosciences Inc (EVLO) were sold and 5,411,255 shares were bought by its insiders, resulting in a net purchase of 5,364,426 shares.
Evelo Biosciences Inc (EVLO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Evelo Biosciences Inc Insider Transactions
Flagship Pioneering Fund Vii General Partner Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Flagship Pioneering Fund Vii General Partner Llc. You might contact Flagship Pioneering Fund Vii General Partner Llc via mailing address: 55 Cambridge Parkway, 8th Floor, Cambridge Ma 02142.